Verition Fund Management
PRAX icon

Verition Fund Management’s Praxis Precision Medicines PRAX Stock Holding History

Verition Fund Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-118,482
Closed -$4.98M – 3957
2025
Q2 		$4.98M Sell
118,482
-81,175
-41% -$3.09M 0.02% 1123
2025
Q1 		$7.56M Sell
199,657
-264,851
-57% -$16.5M 0.04% 601
2024
Q4 		$35.7M Sell
464,508
-94,643
-17% -$6.85M 0.14% 98
2024
Q3 		$32.2M Sell
559,151
-189,169
-25% -$10.2M 0.16% 92
2024
Q2 		$31M Buy
748,320
+202,912
+37% +$9.59M 0.17% 70
2024
Q1 		$33.3M Sell
545,408
-157,592
-22% -$7.07M 0.23% 58
2023
Q4 		$15.7M Buy
703,000
+99,011
+16% +$1.78M 0.12% 137
2023
Q3 		$15.5M Sell
603,989
-95,200
-14% -$1.8M 0.18% 127
2023
Q2 		$12.1M Buy
699,189
+501,700
+254% +$7.68M 0.16% 157
2023
Q1 		$2.4M Buy
197,489
+86,131
+77% +$3.64M 0.03% 645
2022
Q4 		$3.98M Buy
111,358
+51,071
+85% +$1.59M 0.06% 396
2022
Q3 		$2.05M Buy
60,287
+4,272
+8% +$213K 0.02% 881
2022
Q2 		$2.06M Buy
56,015
+40,257
+255% +$4.3M 0.04% 641
2022
Q1 		$2.41M Buy
15,758
+1,605
+11% +$330K 0.03% 834
2021
Q4 		$4.18M Sell
14,153
-13,333
-49% -$3.91M 0.03% 446
2021
Q3 		$7.62M Sell
27,486
-11
-0% -$2.98K 0.07% 195
2021
Q2 		$7.54M Sell
27,497
-4,133
-13% -$1.48M 0.07% 176
2021
Q1 		$15.5M Sell
31,630
-6,667
-17% -$4.74M 0.18% 79
2020
Q4 		$31.6M Buy
+38,297
New +$22.4M 0.28% 60

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Verition Fund Management's PRAX Position: Q3 2025 in Review

Verition Fund Management sold out of Praxis Precision Medicines (PRAX) in Q3 2025, closing a stake of 118,482 shares — an estimated $4.98M sold.

Verition Fund Management first reported a position in PRAX in Q4 2020 and held it in 19 quarters. The position peaked at $35.7M in Q4 2024. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2025.

  • Verition Fund Management reported no remaining Praxis Precision Medicines position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 118,482 Praxis Precision Medicines shares in Q3 2025, an estimated $4.98M.
  • Verition Fund Management first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 19 quarters.
  • Verition Fund Management's Praxis Precision Medicines position peaked at $35.7M in Q4 2024.
  • 152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.